---
title: "Semaglutide"
description: "Semaglutide is a GLP-1 receptor agonist available as weekly injection or daily oral tablet in India for diabetes and obesity."
canonical: "https://www.kesho.health/glossary/semaglutide"
markdown_url: "https://www.kesho.health/md/glossary/semaglutide"
language: "en-IN"
---

# Semaglutide

**Canonical HTML:** https://www.kesho.health/glossary/semaglutide  
**Markdown:** https://www.kesho.health/md/glossary/semaglutide

## Definition

Semaglutide is a long-acting GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management under medical supervision.

## Extended

In India, semaglutide is available as injectable pens and oral tablets. CDSCO-approved generic versions have reduced costs. Monthly expenses typically range ₹8,000–₹20,000. Requires gradual dose titration. In India, these concepts appear in RSSDI and ICMR guidance for type 2 diabetes and obesity care—always confirm details with your prescribing physician.

## Learn more

[Full guide](https://www.kesho.health/blog/semaglutide-india-complete-guide) · [MD](https://www.kesho.health/md/blog/semaglutide-india-complete-guide)

## Related terms

- [glp-1-receptor-agonist](https://www.kesho.health/glossary/glp-1-receptor-agonist)
- [tirzepatide](https://www.kesho.health/glossary/tirzepatide)
- [generic-drug](https://www.kesho.health/glossary/generic-drug)
- [dose-titration](https://www.kesho.health/glossary/dose-titration)